Neurofeedback Rehabilitation Based on Motor Imaging in Patients in the Immobilization Phase

Neurofeedback Rehabilitation Based on Motor Imaging in Patients in the Immobilization Phase

Quick Info:

Status:
Not Yet Recruiting
Estimated Enrollment:
30
Phase:
N/A
Treatment Type:
Device: Videogames
Trial Type:
Single Group Assignment, open-label
Sponsor:
Assistance Publique - Hôpitaux de Paris
Primary Investigator:
Contact Information:

Enrollment Criteria:

Forced Ventilation

Breathing Ability

Percent lung function (FVC) or (SVC)
≥ 65%
Months/Onset

Months Since Onset

Number of months since first
symptoms of ALS
N/A
BiPap Allowed

Non-Invasive Ventilation (NIV)

Can PALS use a BiPAP in the trial?
N/A
DPS Allowed

Diaphragm Pacer (DPS)

Can PALS use a DPS in the trial?
N/A
Edaravone Usage

Edaravone Usage

Can a PALS use edaravone (Radicut/Radicava)
while enrolled in the trial?
Unknown

Update Notes:

There are no update notes for this clinical trial.

Locations:

Paris, France

Other Information:

Purpose: As the prevalence of motor impairment increases with age, the proportion of the population affected by physical limitations is likely to increase in the coming years, considering that one in three people will be over 60 in 2050 (compared to one in five in 2005, INSEE projections). The possibility of reducing recovery time and / or improving the improvement of motor deficits is today a public health issue. The possibility of developing new therapeutic tools using innovative motor imaging rehabilitation technologies is an opportunity to offer rehabilitation adapted to specific disorders, personalized in relation to the patient's performance, and in continuity with the therapist. In this research project, we will use the principle of neurofeedback rehabilitation (EEG) based on motor imaging with a brain-computer interface. Feedback will consist of therapeutic video games.Here, we will test the feasibility of such approach in 10 healthy subjects, 10 patients with amyotrophic lateral sclerosis and 10 patients with uppel shoulder surgery.
Eligibility: 18 Years to 70 Years, all genders, accepting healthy volunteers
Details:
Collaborator(s):
News Articles and Summaries:
ALS Forum:
First Published on Clinicaltrials.gov: 6/4/2018
ClinicalTrials.gov ID: NCT03545451
Trial Protocol as Published on Clinicaltrials.gov:
ClinicalTrials.gov